A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults
Clinical trial NCT07385248 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07385248
- Sponsor
- Addpharma Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2026-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.